More about

Type 2 Diabetes

News
February 09, 2021
2 min read
Save

Type 2 diabetes ‘disproportionately’ affects COVID-19 mortality risk in middle-aged adults

Type 2 diabetes ‘disproportionately’ affects COVID-19 mortality risk in middle-aged adults

Middle-aged adults with type 2 diabetes have a disproportionate risk increase for COVID-19 mortality and should receive priority for early vaccination, according to a research letter published in Diabetologia.

News
February 03, 2021
1 min read
Save

Duodenal mucosal resurfacing plus liraglutide eliminates need for insulin in type 2 diabetes

Adding liraglutide and lifestyle counseling to duodenal mucosal resurfacing eliminated the need for insulin therapy in most patients with type 2 diabetes through 18 months, according to data from a feasibility study.

News
February 01, 2021
4 min read
Save

Type 2 diabetes, metformin use impact risk for breast cancer subtypes

Type 2 diabetes, metformin use impact risk for breast cancer subtypes

Women with type 2 diabetes and those who used metformin did not demonstrate an overall increased risk for breast cancer, according to an analysis of the Sister Study published in Annals of Oncology.

News
February 01, 2021
2 min read
Save

Evidence suggests patients on low-carb diets achieve type 2 diabetes remission

Evidence suggests patients on low-carb diets achieve type 2 diabetes remission

Patients with diabetes who consistently followed a low-carbohydrate diet for 6 months achieved a higher rate of remission — 32% — compared with mostly low-fat diets, according to a systematic review and meta-analysis.

News
January 29, 2021
2 min read
Save

Afternoon vs. morning exercise offers greater benefit for men at high metabolic risk

Afternoon vs. morning exercise offers greater benefit for men at high metabolic risk

Men with excess weight or type 2 diabetes may reap more pronounced metabolic benefits from exercise when training is performed in the afternoon vs. morning, according to findings from a small, retrospective study.

News
January 15, 2021
1 min read
Save

SCORED

SCORED

CV outcomes of sotagliflozin (Sanofi/Lexicon), an SGLT1/SGLT2 inhibitor, in patients with type 2 diabetes and worsening HF or high CV risk.

News
January 14, 2021
1 min read
Save

Link between gut microbiome, diet may reduce risk for health problems

Link between gut microbiome, diet may reduce risk for health problems

A healthy diet may be linked with gut microbes correlate with a lower risk developing conditions including obesity, type 2 diabetes and cardiovascular disease, according to a report published in Nature Medicine.

News
January 08, 2021
1 min read
Save

SGLT2 inhibitors ‘best choice’ for reducing AKI risk vs other glucose-lowering drugs

SGLT2 inhibitors ‘best choice’ for reducing AKI risk vs other glucose-lowering drugs

For patients with type 2 diabetes, SGLT2 inhibitors conferred a lower risk of developing AKI than use of GLP-1 receptor agonists or dipeptidyl peptidase-4 inhibitors, according to a network meta-analysis of clinical trials.

News
January 04, 2021
1 min read
Save

‘Relatively high proportion’ of patients with diabetes experience rapid CKD progression

‘Relatively high proportion’ of patients with diabetes experience rapid CKD progression

Approximately 10% to 17% of patients with type 2 diabetes and newly identified chronic kidney disease had their condition worsen within 2 years, according to a study published in the Clinical Kidney Journal.

News
December 31, 2020
3 min read
Save

No adverse events reported in cohort of high-risk men receiving testosterone therapy

No adverse events reported in cohort of high-risk men receiving testosterone therapy

Testosterone therapy with intramuscular testosterone undecanoate did not result in any adverse cardiovascular or prostate events in a cohort of men with obesity, type 2 diabetes and functional hypogonadism, clinical trial data showed.

View more